What is Mani?
Established in 1956, Mani, Inc. has cultivated a reputation for excellence in the production of high-precision surgical needles and advanced wire-processing technologies. The company operates at the intersection of engineering precision and clinical necessity, providing a comprehensive suite of medical instruments that includes specialized dental equipment and ophthalmic devices. By adhering to rigorous international quality standards, Mani, Inc. serves as a critical supplier to medical professionals worldwide, ensuring that patient safety remains at the forefront of its manufacturing philosophy. Its long-standing history of innovation in material science allows the firm to maintain a competitive edge in the highly regulated medical device market.
How much funding has Mani raised?
Mani has raised a total of $89K across 1 funding round:
Debt
$89K
Debt (2024): $89K with participation from Chase
Key Investors in Mani
Chase
A global financial services firm providing comprehensive banking and investment solutions to support corporate growth and capital structure optimization.
What's next for Mani?
With the infusion of this recent capital, Mani, Inc. is expected to prioritize the scaling of its precision manufacturing infrastructure to meet the rising global demand for high-quality surgical tools. The strategic allocation of these funds will likely focus on enhancing research and development initiatives, particularly in the refinement of ophthalmic and dental instrumentation. As the company transitions through this growth phase, the focus will remain on maintaining its commitment to technological advancement while exploring new market opportunities that align with its core competencies in wire-based medical device production. This financial milestone provides the necessary runway to sustain long-term operational excellence and drive further innovation in clinical care solutions.
See full Mani company page
